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Abstract Human health risks by silver nanoparticle
(AgNP) exposure are likely to increase due to the
increasing number of NP-containing products and
demonstrated adverse effects in various cell lines.
Unfortunately, results from (toxicity) studies are often
based on exposure dose and are oftenmeasured only at a
fixed time point. NP uptake kinetics and the time-
dependent internal cellular concentration are often not
considered. Macrophages are the first line of defense
against invading foreign agents including NPs. How
macrophages deal with the particles is essential for
potential toxicity of the NPs. However, there is a
considerable lack of uptake studies of particles in the
nanometer range and macrophage-like cells. Therefore,
uptake rates were determined over 24 h for three
different AgNPs sizes (20, 50 and 75 nm) in medium
with and without fetal calf serum. Non-toxic concen-
trations of 10 ng Ag/mL for monocytic THP-1 cells,
representing realistic exposure concentration for short-
term exposures, were chosen. The uptake of Ag was
higher in medium without fetal calf serum and showed
increasing uptake for decreasing NP sizes, both on NP
mass and on number basis. Internal cellular concentra-
tions reached roughly 32/10 %, 25/18 % and 21/15 %
of the nominal concentration in the absence of fetal calf
serum/with fetal calf serum for 20-, 50- and 75-nmNPs,
respectively. Our research shows that uptake kinetics in
macrophages differ for variousNP sizes. To increase the
understanding of the mechanism of NP toxicity in cells,
the process of uptake (timing) should be considered.
Keywords Nanoparticle  Uptake kinetics  Size
dependence  Internal cellular concentration  Serum
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Introduction
Nanoparticles (NPs) have dimensions from 1 up to
100 nm by common consensus (European Commis-
sion 2011). Their unique physical and chemical
properties arouse high interest in industry regarding
their use for consumer products and medical applica-
tions as previously described in more detail (Kettler
et al. 2016). The same properties that make them
interesting for industrial applications, especially their
small size and high reactivity, raise serious concerns
regarding a potential risk to human health and biota on
the long term (Christensen et al. 2010) through
exposure via one of the four exposure routes: injection,
dermal and intestinal uptake, and inhalation, the latest
being considered the most important especially during
NP production and processing (Maynard and Kuempel
2005). Exposure to NPs and subsequent uptake have
been shown to affect various cell lines, including
phagocytizing cells like THP-1-derived macrophages
(Foldbjerg et al. 2009; Haase et al. 2011; Park et al.
2011; Singh and Ramarao 2012). Unfortunately,
uptake kinetics and time-dependent internal cellular
concentrations are often neglected in experiments with
measurements after a single fixed point in time and
toxicity is related to exposure dose instead. Uptake is
known to be influenced by NP properties such as size,
as shown for various cell lines in vitro. Unfortunately,
uptake has only been detected after a fixed time point
in many studies (He et al. 2010; Jiang et al. 2008; Lu
et al. 2009; Rejman et al. 2004; Wang et al. 2010).
Uptake of NPs into cells, after contact via one of the
four exposure routes, occurs through two fundamental
biological processes, namely pinocytosis and phago-
cytosis, both tailor-fit for their biological function.
These fundamental biological mechanisms are respon-
sible for the uptake of molecules from the environ-
ment. NPs have been shown to be able to enter cells via
these twomechanisms as summarized by (Kettler et al.
2014). Pinocytosis, a mechanism usually employed by
eukaryotic cells, such as 16HBE14o cells, to take up
small essential nutrients (Conner and Schmid 2003), is
described in more detail elsewhere (Kettler et al.
2016). The vesicles reach sizes of up to 80 nm in
diameter (i.d.) for caveolae-mediated endocytosis or
120 nm i.d. for clathrin-mediated endocytosis. Phago-
cytosis on the other hand is a more specialized
mechanism that can be found in unicellular organisms
as well as in complex multicellular animals (Cosson
and Soldati 2008; Rosales 2005). Phagocytosis as part
of the immune defense in animals is special in the way
that it is restricted to a few types of cells, such as
monocytes, neutrophils and macrophages, to which
THP-1 cells belong. Phagocytosis is a ligand-induced
process, so especially the presence or absence of
serum proteins has great effects on NP uptake as
summarized previously (Kettler et al. 2014); the
formed vesicles reach sizes between 0.5 lm and
10 lm (Watts and Marsh 1992). In the presence of
proteins, a so-called protein corona on the NPs surface
may be formed, leading to uptake that can be
increased, decreased or remained the same, depending
on the surface composition of the NPs, the type of cell
and proteins and/or other biomolecules present on the
NP surface (Ikada and Tabata 1986; Nagayama et al.
2007; Sbarra and Karnovsky 1959).
Very few efforts have been made to study the size-
dependent uptake of NPs with diameters smaller than
100 nm into phagocytizing cells. Uptake rates over
time were determined in two studies only (Chithrani
et al. 2006; Yu et al. 2012), while the majority only
reports uptake at one single point in time (Lu et al.
2009; Tsai et al. 2012; Vonarbourg et al. 2006;
Walkey et al. 2011). In addition, these studies are also
inconclusive about the effect of size on uptake into
phagocytizing cells. To overcome this lack of data,
we determine uptake rates for different AgNPs sizes
in cell culture medium with and without FCS in this
study. Previously it was shown that similar AgNPs
induced cellular toxicity for the murine macrophage
cell line RAW264.7 at concentrations of approxi-
mately 10 lg/mL and higher (Park et al. 2011). In
this study, low non-toxic concentrations of 0.01 lg/
mL were used to study cell uptake without inducing
toxicity. Cells were, therefore, exposed to NPs for
different periods of time over 24 h under realistic
concentrations for short-term exposures. These data
will deliver new insights into the effect of NP size on
their uptake rate and are required to model and
predict NP uptake rates based on easily measurable
NP properties. The number of applications and
produced quantities of NPs are increasing (Hendren
et al. 2013; Nowack and Bucheli 2007; Vance et al.
2015), and especially the combination of empirical
data like ours and modeling will allow for time- and
cost-effective risk assessment of the ever increasing
number of NPs.
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Materials and methods
A detailed description of Materials and methods can
be found elsewhere (Kettler et al. 2016), so here only a
brief description is given.
Nanoparticles
Keeping the possible vesicles size of up to 80 nm in
diameter (i.d.) for caveolae-mediated endocytosis in
mind and to avoid an overlap in the size distribution of
NPs, we chose NPs with diameter of 20, 50 and 75 nm.
The following AgNPs were purchased from
NanoComposix Inc (San Diego, CA): 20 nm Citrate
BioPureTM Silver, 50 nm Citrate BioPureTM Silver
and 75 nm Citrate BioPureTM Silver. The supplier
provided detailed information about the NPs charac-
teristics (Kettler et al. 2016).
Preparation of AgNPs dispersions
Serum proteins present in cell culture growth medium
may have significant effects on uptake (Ikada and
Tabata 1986; Nagayama et al. 2007; Sbarra and
Karnovsky 1959). Therefore, these uptake studies were
conducted withmedia with fetal calf serum (?FCS) and
without (w/o). The dilutions of AgNPs dispersions were
performed in complete cell culturemedium (see below),
either without or with FCS, prior to exposure. Final
exposure concentrations of 0.01 lg Ag/mL were
obtained in several steps of pre-dilutions. We used very
low concentrations of 0.01 lg/mL at which we do not
expect cellular cytotoxicity. Similar AgNPs (20 and
80 nm) of the same supplier induced cellular toxicity for
the murine macrophage cell line RAW264.7 at concen-
trations of approximately 10 lg/mL and higher (Park
et al. 2011). Also for THP-1 cells at low concentrations,
no cytotoxicity was noted for similar (20 and 50 nm)
AgNPs of the same manufacturer (H.M. Braakhuis,
personal communication). In addition, these concentra-
tions represent realistic concentrations for short-term
occupational alveolar lung exposures (Gangwal et al.
2011).
Cells and cell culture conditions
The human monocytic cell line (THP-1, ATCC) was
used in this study. THP-1 cells were cultured in
Roswell Park Memorial Institute (RPMI) 1640 cell
culture growth medium, supplemented with 10 % fetal
calf serum and antibiotics (1 % penicillin–strepto-
mycin (Pen/Strep), all obtained from Gibco, The
Netherlands). This is designated complete medium.
Cells were subcultured usually twice a week not to
exceed a concentration of 1 9 106 viable cells/mL.
Subcultures were started with a cell density of 2 9 105
to 4 9 105 viable cells/mL. Cells were constantly
incubated at 37 C and 5 % CO2 atmosphere. Seven
days prior to exposure to AgNPs, THP-1 were
differentiated to macrophages according to the fol-
lowing procedure: THP-1 were diluted to a concen-
tration of 5 9 105 viable cells/mL to which phorbol
myristate acetate (PMA, Sigma, The Netherlands) was
added to reach a final concentration of 30 ng PMA/
mL. Afterward, 1 9 105 viable cells were added per
well of a 96-well flat-bottomed cell culture plate to
differentiate and become adherent. On day 5, medium
was replaced by fresh medium; on day 7 the cells were
exposed to AgNPs as described in section ‘‘cellular
uptake of AgNPs.’’
Cellular uptake of AgNPs
Cells were seeded in 96-well cell culture plates as
described in the ‘‘cell and cell culture conditions’’-
section and exposed to 200 ll of 0.01 lg/mL AgNP
dispersions. The total exposure times were 0, 2, 4, 8,
12 and 24 h. Note: Due to logistic aspects, the time
points at which the samples have been obtained are
slightly shifted sometimes (maximum 2 h). At the end
of exposure, cells were thoroughly washed with
Dulbecco’s phosphate-buffered saline (DPBS, without
calcium, magnesium, phenol red, Gibco, the Nether-
lands) twice to remove loosely attached Ag ions and/or
NPs from the cell membrane. 200 ll trypsin solution
(Gibco, The Netherlands) was added to detach the
cells from the bottom of the well. Through pipetting, it
was made sure that all cells were detached, and
successful detachment was confirmed by optical
inspection with a light microscope (magnification
509). Each experiment was conducted independently
two times for 20-nm AgNPs, and three times for 50-
and 75-nm AgNPs.
Statistical evaluation and calculations
For the determination of uptake rate constants c and
elimination rate constants k, experimental results were
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evaluated with Microsoft Excel 2010 and the corre-
sponding application ‘‘Solver’’ according to the one
compartment model using Eq. 1. Solver is a tool that
determines the optimal value for variables, here c and
k, within given limits in order to minimize differences
between experimental and model data.
c tð Þ ¼ c
k
 1 ekt  ð1Þ
Fig. 1 Ag amount in cells on mass basis with the fitted line for
three NP sizes and medium without and with fetal calf serum
based on at least two independent experiments (data 1 to data 3).
The light gray data points belonging to data set 3 are indicated as
outliers and were not considered in the determination of the
fitted line. Note Due to logistic aspects, the time points at which
the samples have been obtained are slightly shifted sometimes
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where t is the time of exposure in hours; c is the uptake
rate constant in ng Agwell-1 day-1; and k is the
elimination rate constant in ng Agwell-1 day-1.
Values for k were set to a minimum of 10-8 in order
to avoid divisions by zero during the calculations, and
no other limits are set. Ag concentrations were
standardized to a starting concentration of zero by
subtracting the initial concentration in the cells from
the concentrations in the cells at the later time point.
Results
The results for each replicate, as well as the according
model uptake curves, for the three NP sizes are given
in Fig. 1. The data points displayed in light gray
belonging to data set 3 of the 50-nm samples w/o and
?FCS were evaluated as outliers, likely due to
insufficient washing, and were not considered in the
calculations for the model curve. Uptake clearly
levelled off during the time course for all samples
except for the 50 nm ?FCS where the rate of uptake
stayed constant over 24 h. In our setup, the average
uptake in the absence of FCS was higher than in the
presence of FCS for 20- and 50-nm particles, reaching
highest intracellular concentrations after 24 h. This
effect was most pronounced for 20-nm particles
reaching an approximately threefold higher maximum
concentration after 24 h of exposure in the absence of
FCS than in the presence of it. Average internal
cellular concentrations after 24 h decreased with
increasing particle size in the absence of FCS,
reaching approximately 32, 25 and 21 % of the
nominal concentration for 20-, 50- and 75-nm parti-
cles, respectively.
The uptake and elimination rates on mass basis are
given in Table 1 and Table S1. The uptake rate
constants are significantly different between media
composition for 20- and 50-nm particles. In the
absence of FCS, uptake was also faster for the smallest
particles compared to 50-nm particles as represented
by the significantly different 95 % confidence interval
of the uptake rate constant c. No significant difference
in uptake rate was found between the other NP sizes
due to the large difference in uptake rates between
replicates of 75-nm particles.
The measurand in which results are presented (mass
versus number of NP) is crucial because a size
optimum based on mass does not necessarily lead to
the same uptake optimum regarding NP numbers
(Le´vy et al. 2010). In our case, where uptake on mass
basis is highest for the smallest NP size, the same will
hold true on NP basis. Yet, when expressed on NP
number basis, the difference might become signifi-
cant. To test whether this is the case, and for
comparison with other studies, NP numbers were
calculated. The results without FCS change in so far
that the uptake rate of 20-nm AgNPs differs signifi-
cantly from those of 50- and 75-nm AgNPs. The
uptake rates are not significantly different for 50- and
75-nm AgNPs in the absence of FCS. THP-1 cells
favor the uptake of smaller AgNPs on NP number
basis in the absence of FCS. This is depicted in Fig. 2.
Discussion
Our results show that the cell culture medium com-
position in terms of the presence or absence of FCS
affected the AgNP uptake in the macrophages
Table 1 Overview of the uptake rates based on mass [ng] Ag
NP size [nm], medium type c SD of c 95 % CI of c
20 w/o FCS 1.0 9 10-1 1.5 9 10-2 8.0 9 10-2–1.2 9 10-1
50 w/o FCS 5.6 9 10-2 2.0 9 10-2 3.3 9 10-2–7.8 9 10-2
75 w/o FCS 1.4 9 10-1 1.2 9 10-1 9.5 9 10-3–2.7 9 10-1
20 ? FCS 2.1 9 10-2 1.1 9 10-3 1.9 9 10-2–2.3 9 10-2
50 ? FCS 2.2 9 10-2 5.8 9 10-3 1.6 9 10-2–2.9 9 10-2
75 ? FCS 5.6 9 10-2 3.5 9 10-2 1.6 9 10-2–9.6 9 10-2
Average uptake rate constants c and elimination rate constants k, their standard deviation (SD) and 95 % confidence interval (CI)
based on mass, all given in ng Ag well-1 day-1
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considerably for 20-nm AgNPs (three times higher
uptake) and 50-nm AgNPs, as confirmed by the
literature (Ikada and Tabata 1986; Nagayama et al.
2007; Sbarra and Karnovsky 1959). In medium with
FCS, a so-called protein corona around the AgNPs
might be formed reducing uptake. The protein corona
can lead to repulsive interaction with the negatively
charged cell membrane as shown for anionic bovine
serum albumin (Zhu et al. 2012). Yet, further confir-
mation for NPs of different charge and various types of
serum proteins and other biomolecules that might be
part of the protein corona is needed.When no FCS was
present, final concentrations after 24 h were found to
be higher for the smaller NPs. Uptake changes over
time and levels off after approximately 12 h. Overall,
our results show that uptake kinetics may differ per NP
and therefore should be taken into account in toxicity
studies (Table 2).
After inhalation, lung macrophages are the most
important cells for removal of the inhaled NPs from
Fig. 2 Average Ag content in cells on a NP number basis
calculated from the independent mass-based values for three NP
sizes and medium without and with fetal calf serum as shown in
Fig. 1. The two top graphs show model data for all three NP
sizes for easy comparison and calculated average NP numbers
for 20-nm AgNPs. The four graphs on the bottom show the
average Ag content and the corresponding model date for 50-
and 75-nm AgNPs in more detail. Note Due to logistic aspects,
the time points at which the samples have been obtained are
slightly shifted sometimes, different scaling on the y-axes
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the lung. However, studies determining uptake by
phagocytizing cells for particles in the nanorange and
considering uptake over time are scarce and up to now
inconclusive. Our results show that the amount taken
up was in the order 20[ 50 = 75 nm without FCS
and 50 = 75[ 20 nm in the presence of FCS on mass
basis. In contrast to our findings that uptake is highest
for smallest NPs, uptake by macrophages based on
mass is less effective for smaller PEGylated NPs than
for their larger counterparts (Yu et al. 2012). Uptake
efficiency increases from 30-nm NPs, over 40-nm
NPs, to 100-nm NPs. HeLa cells on the other hand
favor the intermediate size with uptake in the follow-
ing order: 50[ 30[ 74[ 14[ 100 on NP number
basis (Chithrani et al. 2006). It would be interesting to
see whether and how these trends change when
expressed on mass basis.
We therefore recommend that the optimum uptake
is presented in both measurands to allow for compa-
rability between studies. Alternatively, data that allow
for such conversions might be given. Such a conver-
sion is difficult if, e.g., the total diameter is known but
not the thickness of a coating. Levy et al. also showed
that an optimum based on the number of NPs per cell
does not necessarily lead to the same optimum in terms
of mass (Le´vy et al. 2010). Yue et al. graphically
visualized the dependence of the size optimum on the
measurand (number of particles per cell, particle
volume per cell and particle surface area per cell) (Yue
et al. 2010).
Different trends in the optimal particle size for
uptake can be attributed to the numerous experimental
factors that differ between studies, for example
different NP materials and the use of FCS during
incubation and whether opsonization takes place, as
summarized previously by us (Kettler et al. 2014).
Surface charge also affects NP uptake, and an increase
in the absolute zeta potential usually leads to increased
NP uptake in comparison with less charged NPs
(Kettler et al. 2014). For the 50-nm AgNPs used in this
study, charge might to some extend also determine
uptake in comparison with the other AgNPs because
their zeta potential differs from that of the 20- and
75-nm AgNPs from the same manufacturer. This
stresses the need for commercially available NPs with
only one property changed at a time or, ideally, that
reference materials we made available.
Other factors that influence uptake are the use of
various cell lines, different possible uptake mecha-
nisms and exposure concentration. While phagocyto-
sis is usually considered to take place for materials
with sizes larger than 0.5 lm, Kuhn et al. showed that
polystyrene NPs with sizes of 28 nm were taken up by
J774A.1 macrophages via micropinocytosis and
phagocytosis, as well as clathrin-mediated endocyto-
sis (Kuhn et al. 2014). The exact uptake mechanism
for AgNPs into THP-1 cells used in our experiments is
unknown. The uptake mechanism can vary between
differentiated and undifferentiated THP-1 cells
(Lunov et al. 2011). In addition, the determination of
the exact concentration and incubation time for the
various inhibitors is very complex and has to be
adjusted for each cell line separately (Kuhn et al.
2014). Saturation of uptake is observed; therefore,
pinocytosis, a non-saturable process, as the uptake
mechanism can be excluded (Fro¨hlich 2012).
Conclusions
Our study clearly shows that the presence of FCS
reduces cellular uptake for AgNPs of different sizes in
Table 2 Overview of the uptake rates based on AgNP numbers
NP size [nm], medium type c SD of c 95 % CI of c
20 w/o FCS 1.2 9 1010 1.6 9 109 1.0 9 1010–1.5 9 1010
50 w/o FCS 4.5 9 108 1.1 9 108 3.4 9 108–5.7 9 108
75 w/o FCS 3.1 9 108 2.6 9 108 1.8 9 107–6.0 9 108
20 ? FCS 2.5 9 109 1.4 9 108 2.3 9 109–2.7 9 109
50 ? FCS 1.3 9 108 3.4 9 107 9.5 9 107–1.7 9 108
75 ? FCS 1.2 9 108 8.0 9 107 3.3 9 107–2.1 9 108
Average uptake rate constants c and elimination rate constants k, their standard deviation (SD) and 95 % confidence interval (CI)
based on AgNP numbers, all given in AgNPs well-1 day-1
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the macrophage cell line THP-1 and that uptake should
be reported both as NP number and as mass-based
uptake. Our results show that reporting both in every
study is important as the order of uptake in relation to
NP size might change with the measurand and would
be advantageous for easy comparison of results.
Studies that determine uptake kinetics of particles
with sizes below 100 nm by phagocytizing cells are
scarce, stressing the need for further experimental
investigation similar to the presented work. Therefore,
patterns for the effect of particle size on uptake rate
into phagocytizing cells are uncertain. Future devel-
opments will benefit most from studies where either
the same NPs are tested in various phagocytizing cell
lines known for their different endocytic uptake
mechanisms (e.g., clathrin- versus caveolae-mediated
endocytosis) or NPs of different chemical composition
are tested in the same cell line in order to fill
knowledge gaps and resolve apparent contradictions.
Once patterns emerge, extrapolation between different
NPs and between different experimental conditions
will be possible. Modeling will be an indispensable
tool to cover the large and continuously growing
number of engineered NPs and to predict the uptake of
untested NPs.
Acknowledgments We would like to thank Henny Verharen
and Eric Gremmer (both from RIVM) for their technical
assistance.
Funding The present study was supported by NanoNextNL, a
micro- and nanotechnology consortium of the Government of
the Netherlands and 130 partners.
Compliance with ethical standards
Conflict of interest The authors report no conflicts of interest.
Open Access This article is distributed under the terms of the
Creative Commons Attribution 4.0 International License (http://
creativecommons.org/licenses/by/4.0/), which permits unre-
stricted use, distribution, and reproduction in any medium,
provided you give appropriate credit to the original
author(s) and the source, provide a link to the Creative Com-
mons license, and indicate if changes were made.
References
Chithrani BD, Ghazani AA, Chan WCW (2006) Determining
the Size and Shape Dependence of Gold Nanoparticle
Uptake into Mammalian Cells. Nano Lett 6:662–668
Christensen F, Johnston H, Stone V, Aitken R, Hankin S, Peters
S, Aschberger K (2010) Nano-silver–feasibility and chal-
lenges for human health risk assessment based on open
literature. Nanotoxicology 4:284–295. doi:10.3109/
17435391003690549
Commission European (2011) Commission recommendation of
18 October 2011 on the definition of nanomaterial (Text
with EEA relevance). Brussels, Belgium
Conner SD, Schmid SL (2003) Regulated portals of entry into
the cell. Nature 422:37–44
Cosson P, Soldati T (2008) Eat, kill or die: when amoeba meets
bacteria. Curr Opin Microbiol 11:271–276
Foldbjerg R, Olesen P, Hougaard M, Dang DA, Hoffmann HJ,
Autrup H (2009) PVP-coated silver NP and silver ions
induce ROS, apoptosis and necrosis in THP-1 monocytes.
Toxicol Lett 190:156–163. doi:10.1016/j.toxlet.2009.07.
009
Fro¨hlich E (2012) The role of surface charge in cellular uptake
and cytotoxicity of medical nanoparticles. Int J Nanomed
7:5577–5591. doi:10.2147/IJN.S36111
Gangwal S, Brown J, Wang A, Houck K, Dix D, Kavlock R,
Hubal E (2011) Informing selection of nanomaterial con-
centrations for ToxCast in vitro testing based on occupa-
tional exposure potential. Environ Health Perspect
119:1539–1546. doi:10.1289/ehp.1103750
Haase A et al (2011) Toxicity of silver nanoparticles in human
macrophages: uptake, intracellular distribution and cellular
responses. J Phys: Conf Ser 304:012030. doi:10.1088/
1742-6596/304/1/012030
He C, Hu Y, Yin L, Tang C, Yin C (2010) Effects of particle size
and surface charge on cellular uptake and biodistribution of
polymeric nanoparticles. Biomaterials 31:3657–3666
Hendren C, LowryM, Grieger K, Money E, Johnston J, Wiesner
M, Beaulieu S (2013) Modeling approaches for charac-
terizing and evaluating environmental exposure to engi-
neered nanomaterials in support of risk-based decision
making. Environ Sci Technol 47:1190–1205
Ikada Y, Tabata Y (1986) Phagocytosis of bioactive micro-
spheres. J Bioact Compatible Polym 1:32–46
JiangW, KimBYS, Rutka JT, ChanWCW (2008) Nanoparticle-
mediated cellular response is size-dependent. Nat Nan-
otechnol 3:145–150
Kettler K, Veltman K, van de Meent D, van Wezel A, Hendriks
AJ (2014) Cellular uptake of nanoparticles as determined
by particle properties. experimental conditions, and cell
type. Environ Toxicol Chem 33:481–492. doi:10.1002/etc.
2470
Kettler K, Krystek P, Giannakou C, Hendriks AJ, Jong WHd
(2016) Exploring the effect of silver nanoparticle size and
medium composition on uptake into pulmonary epithelial
16HBE14o-cells. doi: 10.1007/s11051-016-3493-z
Kuhn DA, Vanhecke D, Michen B, Blank F, Gehr P, Petri-Fink
A, Rothen-Rutishauser B (2014) Different endocytotic
uptake mechanisms for nanoparticles in epithelial cells and
macrophages. Beilstein J Nanotechnol 5:1625–1636.
doi:10.3762/bjnano.5.174
Le´vy R, Shaheen U, Cesbron Y, Se´e V (2010) Gold nanoparti-
cles delivery in mammalian live cells: a critical review.
Nano Rev. doi:10.3402/nano.v1i0.4889
Lu F, Wu S-H, Hung Y, Mou C-Y (2009) Size effect on cell
uptake in well-suspended, uniform mesoporous silica
286 Page 8 of 9 J Nanopart Res (2016) 18:286
123
nanoparticles. Small 5:1408–1413. doi:10.1002/smll.
200900005
Lunov O et al (2011) Differential uptake of functionalized
polystyrene nanoparticles by human macrophages and a
monocytic cell line. ACS Nano 5:1657–1669. doi:10.1021/
nn2000756
Maynard A, Kuempel E (2005) Airborne nanostructured parti-
cles and occupational health. J Nanopart Res 7:587–614
Nagayama S, Ogawara K-I, Fukuoka Y, Higaki K, Kimura T
(2007) Time-dependent changes in opsonin amount asso-
ciated on nanoparticles alter their hepatic uptake charac-
teristics. Int J Pharm 342:215–221
Nowack B, Bucheli TD (2007) Occurrence, behavior and effects
of nanoparticles in the environment. Environ Pollut
150:5–22
Park MVDZ et al (2011) The effect of particle size on the
cytotoxicity, inflammation, developmental toxicity and
genotoxicity of silver nanoparticles. Biomaterials
32:9810–9817. doi:10.1016/j.biomaterials.2011.08.085
Rejman J, Oberle V, Zuhorn IS, Hoekstra D (2004) Size-de-
pendent internalization of particles via the pathways of
clathrin- and caveolae-mediated endocytosis. Biochem J
377:159–169
Rosales C (2005) Mechanisms of phagocytosis. Springer, New
York
Sbarra AJ, Karnovsky ML (1959) The Biochemical Basis of
Phagocytosis. J Biol Chem 243:1355–1362
Singh RP, Ramarao P (2012) Cellular uptake, intracellular
trafficking and cytotoxicity of silver nanoparticles. Toxicol
Lett 213:249–259. doi:10.1016/j.toxlet.2012.07.009
Tsai C, Lu S, Hu C, Yeh C, Lee G, Lei H (2012) Size-dependent
attenuation of TLR9 signaling by gold nanoparticles
in macrophages. J Immunol 188:68–76. doi:10.4049/
jimmunol.1100344
Vance ME, Kuiken T, Vejerano EP, McGinnis SP, Hochella MF
Jr, Rejeski D, Hull MS (2015) Nanotechnology in the real
world: redeveloping the nanomaterial consumer products
inventory. Beilstein J Nanotechnol 6:1769–1780
Vonarbourg A, Passirani C, Saulnier P, Simard P, Leroux JC,
Benoit JP (2006) Evaluation of pegylated lipid nanocap-
sules versus complement system activation and macro-
phage uptake. J Biomed Mater Res 78:620–628. doi:10.
1002/jbm.a.30711
Walkey CD, Olsen JB, Guo H, Emili A, Chan WCW (2011)
Nanoparticle size and surface chemistry determine serum
protein adsorption and macrophage uptake. J Am Chem
Soc 134:2139–2147. doi:10.1021/ja2084338
Wang S-H, Lee C-W, Chiou A, Wei P-K (2010) Size-dependent
endocytosis of gold nanoparticles studied by three-di-
mensional mapping of plasmonic scattering images.
J Nanobiotechnol. doi:10.1186/1477-3155-8-33
Watts C, Marsh M (1992) Endocytosis: what goes in and how?
J Cell Sci 103:1–8
Yu S et al (2012) Size- and charge-dependent non-specific
uptake of PEGylated nanoparticles by macrophages. Int J
Nanomed 7:799–813. doi:10.2147/IJN.S28531
Yue H, Wei W, Yue Z, Lv P, Wang L, Ma G, Su Z (2010)
Particle size affects the cellular response in macrophages.
Eur J Pharm Sci 41:650–657. doi:10.1016/j.ejps.2010.09.
006
Zhu Z-J, Posati T, Moyano DF, Tang R, Yan B, Vachet RW,
Rotello VM (2012) The interplay of monolayer structure
and serum protein interactions on the cellular uptake of
gold nanoparticles. Small. doi:10.1002/smll.201200794
J Nanopart Res (2016) 18:286 Page 9 of 9 286
123
